ConductScience.org, home

Paper884658

The effect of vincristine on methotrexate uptake and inhibition of DNA synthesis by human lymphoblastoid cells.

Warren RD and 2 others. Cancer Res, 1977. Cited by 33 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The effect of vincristine on methotrexate uptake and inhibition of DNA synthesis by human lymphoblastoid cells. Papers, record 884658. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/884658

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The effect of vincristine on methotrexate uptake and inhibition of DNA synthesis by human lymphoblastoid cells.
PubMed
Journal
Cancer Res
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
1.47
iCite
Revised in PubMed
2015-11-19
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Warren RDR D
2Nichols APA P
3Bender RAR A

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DNAMajor topic
LymphocytesMajor topic
MethotrexateMajor topic
VincristineMajor topic
Cell Line
Deoxyuridine
Drug Therapy, Combination
Humans
Leukemia

Source PubMed

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
31,691,080Coadministration of vindesine with high-dose methotrexate therapy increases acute kidney injury via BCRP, MRP2, and OAT1/OAT3.Cancer Chemother Pharmacol2020https://conductscience.org/library/papers/31691080PubMed
8,500,226Interactions of vinblastine and vincristine with methotrexate transport in isolated rat hepatocytes.Cancer Chemother Pharmacol1993https://conductscience.org/library/papers/8500226PubMed
8,126,058Effects of hyaluronidase on doxorubicin penetration into squamous carcinoma multicellular tumor spheroids and its cell lethality.J Cancer Res Clin Oncol1994https://conductscience.org/library/papers/8126058PubMed
6,954,016
Treatment of patients with refractory myelogenous leukemia with BCOMM[1,3-bis-chloro(2-chloroethyl)-1-nitrosourea (BCNU), oncovin (vincristine), cyclophosphamide, high-dose methotrexate and methyl-glyoxal bis-guanylhydrazone (MGBG)].
Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/6954016PubMed
3,719,898Methotrexate-vindesine association in head and neck cancer: modification of methotrexate's hydroxylation in presence of vindesine.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3719898PubMed
292,535Vincristine-methotrexate combination chemotherapy and the influence of weight loss on experimental tumour growth.Cancer Chemother Pharmacol1979https://conductscience.org/library/papers/292535PubMed
78,795Antineoplastic drugs: clinical pharmacology and therapeutic use.Drugs1978https://conductscience.org/library/papers/78795PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/884658

GET https://conductscience.org/api/papers/v1/884658/authors